Evidence map›Paper›PMID 35288335›Full record

ArticleOphthalmology. Glaucoma

Clinicians' Use of Quantitative Information while Assessing the Rate of Functional Progression in Glaucoma.

Stuart K Gardiner, Robert M Kinast, Carlos Gustavo De Moraes, Donald L Budenz, Jin Wook Jeoung, John T Lind, Jonathan S Myers, Kouros Nouri-Mahdavi, Lindsay A Rhodes, Nicholas G Strouthidis and 2 more

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology. Glaucoma. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 4 countries.

Stuart K GardinerDevers Eye Institute, Legacy Health, Portland, Oregon. Electronic address: sgardiner@deverseye.org.
Robert M KinastDevers Eye Institute, Legacy Health, Portland, Oregon.
Carlos Gustavo De MoraesColumbia University Irving Medical Center, New York, New York.
Donald L BudenzDepartment of Ophthalmology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Jin Wook JeoungSeoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
John T LindGlick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana.
Jonathan S MyersWills Eye Hospital, Philadelphia, Pennsylvania.
Kouros Nouri-MahdaviStein Eye Institute, University of California Los Angeles, Los Angeles, California.
Lindsay A RhodesUniversity of Alabama at Birmingham, Birmingham, Alabama.
Nicholas G StrouthidisNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom; Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Teresa C ChenHarvard Medical School, Massachusetts Eye & Ear, Boston, Massachusetts.
Steven L MansbergerDevers Eye Institute, Legacy Health, Portland, Oregon.
Legacy Health · USColumbia University Irving Medical Center · USHarvard University · USIndiana University – Purdue University Indianapolis · USSeoul National University Hospital · KRUniversity College London · GBUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · USUniversity of North Carolina at Chapel Hill · USWills Eye Hospital · US

Funding

Functional Testing for GlaucomaR01EY020922 · NEI · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI GARDINER, STUART · 2011 to 2021
$3.2M
Blood flow and hemodynamics in glaucomaR01EY031686 · NEI · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI GARDINER, STUART · 2020 to 2023
$1.8M
NEI NIH HHS R01 EY020922NEI NIH HHS R01 EY031686
6 · The paper itself

Abstract

purposeClinicians use both global and point-wise information from visual fields to assess the rate of glaucomatous functional progression. We asked which objective, quantitative measures best correlated with subjective assessment by glaucoma experts. In particular, we aimed to determine how much that judgment was based on localized rates of change vs. on global indices reported by the perimeter.

designProspective cohort study.

participantsEleven academic, expert glaucoma specialists independently scored the rate of functional progression, from 1 (improvement) to 7 (very rapid progression), for a series of 5 biannual clinical printouts from 100 glaucoma or glaucoma suspect eyes of 51 participants, 20 of which were scored twice to assess repeatability.

methodsRegression models were used to predict the average of the 11 clinicians' scores based on objective rates of change of mean deviation (MD), visual field index (VFI), pattern standard deviation (PSD), the Nth fastest progressing location, and the Nth fastest progressing of 10 anatomically defined clusters of locations after weighting by eccentricity.

main outcome measuresCorrelation between the objective rates of change and the average of the 11 clinicians' scores.

resultsThe average MD of the study eyes was -2.4 dB (range, -16.8 to +2.8 dB). The mean clinician score was highly repeatable, with an intraclass correlation coefficient of 0.95. It correlated better with the rate of change of VFI (pseudo-R

conclusionsExpert academic glaucoma specialists' assessment of the rate of change correlated best with VFI rates, except in eyes with a VFI near the ceiling of 100%. Sensitivities averaged within clusters of locations have been shown to detect change sooner, but the experts' opinions correlated more closely with global VFI. This could be because it is currently the only index for which the perimeter automatically provides a quantitative estimate of the rate of functional progression.

Indexed as

GlaucomaVisual Field TestsDisease ProgressionHumansProspective StudiesVision DisordersClinical careDiagnosticsPerimetryProgressionSurvey

Identifiers

PMID35288335
PMCPMC9464792
OpenAlexW4220883498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.